Immatics Biotechnologies Gmbh Stock Market Value
| IMTXW Stock | USD 0.41 0.01 2.38% |
| Symbol | Immatics |
Immatics Biotechnologies Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics Biotechnologies. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.766 | Quarterly Revenue Growth (0.16) | Return On Assets (0.12) | Return On Equity (0.24) |
The market value of Immatics Biotechnologies is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Immatics Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics Biotechnologies' market value can be influenced by many factors that don't directly affect Immatics Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immatics Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immatics Biotechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immatics Biotechnologies.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Immatics Biotechnologies on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding immatics biotechnologies GmbH or generate 0.0% return on investment in Immatics Biotechnologies over 30 days. Immatics Biotechnologies is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Immatics Biotechnologies is entity of United States More
Immatics Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immatics Biotechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess immatics biotechnologies GmbH upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 66.99 | |||
| Value At Risk | (14.74) | |||
| Potential Upside | 12.15 |
Immatics Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immatics Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immatics Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Immatics Biotechnologies historical prices to predict the future Immatics Biotechnologies' volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (2.29) | |||
| Total Risk Alpha | (3.62) | |||
| Treynor Ratio | (1.02) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immatics Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immatics Biotechnologies Backtested Returns
Immatics Biotechnologies holds Efficiency (Sharpe) Ratio of -0.21, which attests that the entity had a -0.21% return per unit of risk over the last 3 months. Immatics Biotechnologies exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immatics Biotechnologies' Risk Adjusted Performance of (0.15), market risk adjusted performance of (1.01), and Standard Deviation of 10.07 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.0, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immatics Biotechnologies will likely underperform. At this point, Immatics Biotechnologies has a negative expected return of -2.24%. Please make sure to check out Immatics Biotechnologies' treynor ratio and the relationship between the skewness and day typical price , to decide if Immatics Biotechnologies performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.61 |
Good predictability
immatics biotechnologies GmbH has good predictability. Overlapping area represents the amount of predictability between Immatics Biotechnologies time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immatics Biotechnologies price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Immatics Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Immatics Biotechnologies lagged returns against current returns
Autocorrelation, which is Immatics Biotechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immatics Biotechnologies' stock expected returns. We can calculate the autocorrelation of Immatics Biotechnologies returns to help us make a trade decision. For example, suppose you find that Immatics Biotechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immatics Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immatics Biotechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immatics Biotechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immatics Biotechnologies stock over time.
Current vs Lagged Prices |
| Timeline |
Immatics Biotechnologies Lagged Returns
When evaluating Immatics Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immatics Biotechnologies stock have on its future price. Immatics Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immatics Biotechnologies autocorrelation shows the relationship between Immatics Biotechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in immatics biotechnologies GmbH.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.